Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis Assessment and Clinical Studies Group survey
Clinical Rheumatology, 05/11/2012Schoeman CC et al.
This survey suggests that statins are commonly used by physicians specializing in the treatment of patients with idiopathic inflammatory myositis (IIM) and that some myositis patients worsen with statin use and may improve on dechallenge. More research regarding the safety of lipid–lowering agents in patients with IIM is warranted.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.